作者
Arash Salmaninejad, Khandan Ilkhani, Havva Marzban, Jamshid G Navashenaq, Samira Rahimirad, Fatemeh Radnia, Meysam Yousefi, Zahra Bahmanpour, Sara Azhdari, Amirhossein Sahebkar
发表日期
2021/8/1
来源
Current pharmaceutical design
卷号
27
期号
28
页码范围
3161-3169
出版商
Bentham Science Publishers
简介
DNA damage usually happens in all cell types, which may originate from endogenous sources (i.e., DNA replication errors) or be emanated from radiations or chemicals. These damages range from changes in few nucleotides to significant structural abnormalities on chromosomes and, if not repaired, could disturb the cellular homeostasis or cause cell death. As the most significant response to DNA damage, DNA repair provides biological pathways by which DNA damages are corrected and returned into their natural circumstance. However, an aberration in the DNA repair mechanisms may result in genomic and chromosomal instability and the accumulation of mutations. The activation of oncogenes and/or inactivation of tumor suppressor genes is a serious consequence of genomic and chromosomal instability and may bring the cells into a cancerous phenotype. Therefore, genomic and chromosomal instability is …
引用总数
学术搜索中的文章
A Salmaninejad, K Ilkhani, H Marzban, JG Navashenaq… - Current pharmaceutical design, 2021